Skip to main content

Where health innovation becomes commercial reality

Healthcare innovation often shows early promise but struggles to reach adoption and commercial growth. This is especially true in university and NHS settings, where strong clinical or academic expertise may not be matched by support across product, compliance, evidence, and go-to-market strategy. Blüm helps bridge that gap by turning promising innovation into ventures that are commercially viable, regulation-ready, and built for real-world healthcare adoption.

From innovation to adoption

We support health tech ventures from early assessment through to venture design, product development, NHS market entry, and international commercialisation planning.

We build with two markets in mind: the NHS, where adoption depends on pathway fit, evidence, value, and deployability, and international markets, where success depends on a scalable proposition, repeatable go-to-market strategy, and credible market entry planning.

Blüm has partnered with Browne Jacobson to launch Spin-out as a Service, a new offer helping NHS trusts and public-sector organisations turn promising innovations into scalable ventures. By combining legal, commercial and technical expertise in one coordinated model, the service provides a clearer, more practical route from concept to company.

From innovation to adoption

The commercial, clinical, and delivery capabilities behind stronger health tech spinouts

Venture strategy and spinout design

We help define the business model, venture structure, and commercial priorities needed to build momentum.

Product, software, and delivery planning

We shape the roadmap, technical direction, and product strategy required to move towards deployment.

Regulatory and compliance support

We help align the venture with relevant safety, governance, and regulatory requirements from an early stage.

NHS adoption and commercial strategy

We help ventures develop the positioning and route-to-market needed to win in the NHS.

International growth planning

We support market-entry thinking that helps ventures move from UK credibility to wider commercial opportunity.

Multidisciplinary venture-building support

We combine commercial, clinical, technical, and compliance expertise to help ventures progress more effectively.

Why Blüm?

Health tech commercialisation requires more than good innovation. It requires an understanding of clinical pathways, evidence, product delivery, regulation, procurement, and scale.

Our role is to help answer the questions that determine whether an innovation can become a real business: is the route to adoption credible, what evidence is needed, how should the proposition be positioned, and what operating model gives the venture the best chance of success?

Blüm helps clients bridge the gap between invention and execution. With expertise spanning software, compliance, product development, and commercialisation, and led by a clinician-entrepreneur founder, we help build ventures that are not only technically strong, but commercially credible and designed for real-world adoption.

FAQs about our Spin Out Venture Service

Venture building means helping turn innovation into a viable company, not just offering advice in one area. We support across proposition, venture design, product, compliance, evidence, NHS market entry, and growth planning.

We work with universities, NHS innovators, clinicians, researchers, and founders who are developing high-potential healthcare innovation and need help turning it into a real venture.

No. We can support ventures at different stages, from early opportunity assessment through to product development, NHS adoption planning, and international commercialisation.

Yes. We help ventures shape the evidence, positioning, and commercial strategy needed to move from pilot to procurement and broader adoption.

Yes. Our support can include product strategy, software planning, technical direction, and wider digital health delivery input.

Yes. We support regulatory, clinical safety, and governance planning so ventures can build on stronger foundations.

Start with a free spin-out diagnostic

Get an expert assessment of your opportunity, key risks and next steps from Blüm and Browne Jacobson.